Compare DYN & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DYN | AEHR |
|---|---|---|
| Founded | 1984 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.0B |
| IPO Year | 2020 | 1997 |
| Metric | DYN | AEHR |
|---|---|---|
| Price | $20.97 | $97.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 3 |
| Target Price | ★ $37.00 | $29.50 |
| AVG Volume (30 Days) | 1.8M | ★ 1.8M |
| Earning Date | 05-04-2026 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $58,968,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $71.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.25 | $12.45 |
| 52 Week High | $25.00 | $126.62 |
| Indicator | DYN | AEHR |
|---|---|---|
| Relative Strength Index (RSI) | 63.85 | 47.21 |
| Support Level | $16.47 | $81.17 |
| Resistance Level | $21.57 | $105.62 |
| Average True Range (ATR) | 1.14 | 12.10 |
| MACD | 0.35 | -1.11 |
| Stochastic Oscillator | 89.66 | 28.82 |
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.